Report

Biosimilars Action Plan: Balancing Innovation and Competition

The U.S. Food and Drug Administration released the Biosimilars Action Plan to provide information about the key actions the agency is taking to encourage innovation and competition among biologics and the development of biosimilars.

https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/Biosimilars/UCM613761.pdf?utm_campaign=20180815%20MCMi&utm_medium=email&utm_source=Eloqua

SHARE:

TAGS:

COMMENTS

Report

Biosimilars Action Plan: Balancing Innovation and Competition

The U.S. Food and Drug Administration released the Biosimilars Action Plan to provide information about the key actions the agency is taking to encourage innovation and competition among biologics and the development of biosimilars.

https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/Biosimilars/UCM613761.pdf?utm_campaign=20180815%20MCMi&utm_medium=email&utm_source=Eloqua

SHARE:

TAGS:

COMMENTS

Translate Β»